Article (Scientific journals)
Mutational analysis of VIM-2 reveals an essential determinant for metallo-beta-lactamase stability and folding.
Borgianni, Luisa; Vandenameele, Julie; Matagne, André et al.
2010In Antimicrobial Agents and Chemotherapy, 54 (8), p. 3197-204
Peer Reviewed verified by ORBi
 

Files


Full Text
Borgianni_AAC_54_3197.pdf
Publisher postprint (593.06 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
metallo-beta-lactamase; saturation mutagenesis; folding; catalytic activity
Abstract :
[en] Metallo-beta-lactamase (MBL)-producing bacteria are emerging worldwide and represent a formidable threat to the efficacy of relevant beta-lactams, including carbapenems, expanded-spectrum cephalosporins, and beta-lactamase inactivator/beta-lactam combinations. VIM-2 is currently the most widespread MBL and represents a primary target for MBL inhibitor research, the clinical need for which is expected to further increase in the future. Using a saturation mutagenesis approach, we probed the importance of four residues (Phe-61, Ala-64, Tyr-67, and Trp-87) located close to the VIM-2 active site and putatively relevant to the enzyme activity based on structural knowledge of the enzyme and on structure-activity relationships of the subclass B1 MBLs. The ampicillin MIC values shown by the various mutants were affected very differently depending on the randomized amino acid position. Position 64 appeared to be rather tolerant to substitution, and kinetic studies showed that the A64W mutation did not significantly affect substrate hydrolysis or binding, representing an important difference from IMP-type enzymes. Phe-61 and Tyr-67 could be replaced with several amino acids without the ampicillin MIC being significantly affected, but in contrast, Trp-87 was found to be critical for ampicillin resistance. Further kinetic and biochemical analyses of W87A and W87F variants showed that this residue is apparently important for the structure and proper folding of the enzyme but, surprisingly, not for its catalytic activity. These data support the critical role of residue 87 in the stability and folding of VIM-2 and might have strong implications for MBL inhibitor design, as this residue would represent an ideal target for interaction with small molecules.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Borgianni, Luisa;  Università di Siena > Dipartimento di Biologia Molecolare > Laboratorio di Fisiologia e Biotecnologia dei Microrganismi
Vandenameele, Julie ;  Université de Liège - ULiège > Département des sciences de la vie > Enzymologie et repliement des protéines
Matagne, André  ;  Université de Liège - ULiège > Département des sciences de la vie > Enzymologie et repliement des protéines
Bini, Luca;  Università di Siena > Dipartimento di Biologia Molecolare > Laboratorio di Fisiologia e Biotecnologia dei Microrganismi
Bonomo, Robert A;  Louis Stokes Cleveland > Department of Veterans Affairs Medical Center
Frère, Jean-Marie ;  Université de Liège - ULiège > Centre d'ingénierie des protéines
Rossolini, Gian Maria;  Università di Siena > Dipartimento di Biologia Molecolare > Laboratorio di Fisiologia e Biotecnologia dei Microrganismi
Docquier, Jean-Denis ;  Université de Liège - ULiège > Département des sciences de la vie > Centre d'ingénierie des protéines
Language :
English
Title :
Mutational analysis of VIM-2 reveals an essential determinant for metallo-beta-lactamase stability and folding.
Publication date :
2010
Journal title :
Antimicrobial Agents and Chemotherapy
ISSN :
0066-4804
eISSN :
1098-6596
Publisher :
American Society for Microbiology (ASM), Washington, United States - District of Columbia
Volume :
54
Issue :
8
Pages :
3197-204
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 09 August 2010

Statistics


Number of views
70 (8 by ULiège)
Number of downloads
2 (2 by ULiège)

Scopus citations®
 
50
Scopus citations®
without self-citations
24
OpenCitations
 
47

Bibliography


Similar publications



Contact ORBi